Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.

Higher vitamin D status was not beneficially associated with responses to therapy; if anything, patients with higher vitamin D concentrations were less likely to attain SVR. Our data do not support a role for vitamin D supplementation as an adjuvant therapy for HCV.

Bibliographic Details
Main Authors: Erikka Loftfield, Thomas R O'Brien, Ruth M Pfeiffer, Charles D Howell, Ron Horst, Ludmila Prokunina-Olsson, Stephanie J Weinstein, Demetrius Albanes, Timothy R Morgan, Neal D Freedman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5104464?pdf=render

Internet

http://europepmc.org/articles/PMC5104464?pdf=render

Similar Items